Name: Immunoglobulin G as a Therapeutic Drug and its FDA Regulation (en Inglés)
SKU: 57564054
Price: 984.22 MXN
Availability: InStock
Author: Muhammed, Yusuf
ISBN: 9786202530651

portada Immunoglobulin G as a Therapeutic Drug and its FDA Regulation (en Inglés)

Immunoglobulin G as a Therapeutic Drug and its FDA Regulation (en Inglés)

Formato

Libro Físico

Autor

Yusuf Muhammed

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.3 cm

Peso

0.09 kg.

ISBN13

9786202530651

Categorías

Bioquímica

Immunoglobulin G as a Therapeutic Drug and its FDA Regulation (en Inglés)

Yusuf Muhammed (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 23 a 28 días háb.

$ 1,640.37$ 984.22

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 984.22

¡Envío Gratis! Llega entre el 06 Oct y el 14 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Immunoglobulin G as a Therapeutic Drug and its FDA Regulation (en Inglés)"

The complex protein molecule called immunoglobulin G is the widely studied protein before the invention of automated protein sequencing and recombinant DNA technology, their application as disease therapeutics date back to their detailed knowledge from the structure, immunology, biology, and synthesis of large-quality biopharmaceuticals. Therefore, it was reviewed that immunoglobulin G intended to be used for a therapeutic drug can be developed using hybridoma technology, followed by expansion of the cell lines on industrial scale bioreactor for mass production. Among the subclasses of immunoglobulin G, IgG1 is the best for drug development. Some of the therapeutic potential of immunoglobulin G as a potential drug include its utilization for disease diagnosis, treatment of cancer, viral, bacterial, and fungus infection. Before the manufacturing of mAb by biopharmaceutical companies, there is a need for a license and investigational new drug application with the FDA. Hence, this article reviewed immunoglobulin G, its potential, subclasses, production, and FDA regulation.